National Psoriasis Foundation’s COVID guidelines top recent psoriasis news

Psoriasis news in the first half of 2021 has included updates regarding the COVID-19 vaccine and research regarding treatment options.

Here are the top five most-read psoriasis-related articles on Healio in the first half of this year.

National Psoriasis Foundation recommends COVID-19 vaccine in pandemic guidelines

The guidelines, published in Journal of the American Academy of Dermatology, were developed by a task force of 18 dermatology, rheumatology, epidemiology, infectious diseases and critical care physicians. Read more.

Bimekizumab shows rapid, effective treatment of plaque psoriasis

The multicenter, randomized, double-blind, active-comparator, placebo-controlled BE VIVID trial included 567 patients and took place at 105 locations across 11 countries. Read more.

Nail psoriasis in PsA linked to more severe symptoms, worse quality of life

Patients with nail psoriasis alongside psoriatic arthritis demonstrate worse disease activity, quality of life and work productivity than those without nail involvement, according to data published in The Journal of Rheumatology. Read more.

Depression rate lower with apremilast treatment for psoriasis, psoriatic arthritis

Depression rates were lower in patients treated with apremilast monotherapy for psoriasis or psoriatic arthritis and higher in those treated with biologics, corticosteroids and non-apremilast combinations, according to a presentation at Maui Derm for Dermatologists. Read more.

Psoriasis, metabolic syndrome associated with cardiovascular risk

Higher systemic inflammation and cardiovascular risk factors were identified in individuals with psoriasis and metabolic syndrome, according to a study published in Journal of the American Academy of Dermatology. Read more.